{"id":229533,"date":"2026-01-21T21:31:22","date_gmt":"2026-01-22T03:31:22","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/apoe4-to-apoe2-allelic-switching-in-mice-improves-alzheimers-disease-related-metabolic-signatures-neuropathology-and-cognition"},"modified":"2026-01-21T21:31:22","modified_gmt":"2026-01-22T03:31:22","slug":"apoe4-to-apoe2-allelic-switching-in-mice-improves-alzheimers-disease-related-metabolic-signatures-neuropathology-and-cognition","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/apoe4-to-apoe2-allelic-switching-in-mice-improves-alzheimers-disease-related-metabolic-signatures-neuropathology-and-cognition","title":{"rendered":"APOE4 to APOE2 allelic switching in mice improves Alzheimer\u2019s disease-related metabolic signatures, neuropathology and cognition"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/apoe4-to-apoe2-allelic-switching-in-mice-improves-alzheimers-disease-related-metabolic-signatures-neuropathology-and-cognition.jpg\"><\/a><\/p>\n<p>APOE allele switching improves Alzheimer\u2019s in mice.<\/p>\n<p>Type of apolipoprotein E (APOE) allele carried by individuals is a major risk factor in Alzheimer\u2019s disease (AD). For example, compared to individuals carrying two copies of the APOE \u03b54 allele, \u03b52 homozygotes have an approximate 99% reduction in late-onset Alzheimer\u2019s disease (AD) risk.<\/p>\n<p>The authors in this study developed a knock-in mouse model that allows for an inducible \u2018switch\u2019 between risk and protective alleles (APOE4s2). These mice synthesize E4 at baseline and E2 after tamoxifen administration.<\/p>\n<p>A whole-body allelic switch resulted in a metabolic profile resembling E2\/E2 humans and drives AD-relevant alterations in the lipidome and single-cell transcriptome, particularly in astrocytes.<\/p>\n<p>E4 to E2 switching improved cognition, decreased amyloid pathology, lowered gliosis and reduced plaque-associated apolipoprotein E.<\/p>\n<p>Thus, APOE replacement may be a viable strategy for future gene editing approaches to simultaneously reduce multiple AD-associated pathologies. sciencenewshighlights ScienceMission <a href=\"https:\/\/sciencemission.com\/APOE4-to-APOE2-allelic-switching\">https:\/\/sciencemission.com\/APOE4-to-APOE2-allelic-switching<\/a><\/p>\n<hr>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2026\/01\/apoe4-to-apoe2-allelic-switching-in-mice-improves-alzheimers-disease-related-metabolic-signatures-neuropathology-and-cognition\">Continue reading \u201cAPOE4 to APOE2 allelic switching in mice improves Alzheimer\u2019s disease-related metabolic signatures, neuropathology and cognition\u201d | &gt;<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>APOE allele switching improves Alzheimer\u2019s in mice. Type of apolipoprotein E (APOE) allele carried by individuals is a major risk factor in Alzheimer\u2019s disease (AD). For example, compared to individuals carrying two copies of the APOE \u03b54 allele, \u03b52 homozygotes have an approximate 99% reduction in late-onset Alzheimer\u2019s disease (AD) risk. The authors in this [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11,412,47],"tags":[],"class_list":["post-229533","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical","category-genetics","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/229533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=229533"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/229533\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=229533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=229533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=229533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}